Clinical Trial Update: An Observational Study to Evaluate the Efficacy of Lodoz in a Population of Hypertensive Patients

View source ↗

Summary

A completed observational study evaluating the efficacy of Lodoz in hypertensive patients, sponsored by Merck KGaA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Lodoz

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Hypertension | Status: COMPLETED